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Abstract  
Glioblastoma (GBM) is a lethal primary brain tumor characterized by treatment 
resistance and inevitable tumor recurrence, both of which are driven by a 
subpopulation of GBM cancer stem-like cells (GSC) with tumorigenic and selfrenewal 
properties. Despite having broad implications for understanding GSC phenotype, the 
determinants of upregulated DNA damage response (DDR) and subsequent radiation 
resistance in GSC are unknown and represent a significant barrier to developing 
effective GBM treatments. In this study, we show that constitutive DDR activation and 
radiation resistance are driven by high levels of DNA replication stress (RS). CD133+ 
GSC exhibited reduced DNA replication velocity and a higher frequency of stalled 
replication forks than CD133- non-GSC in vitro; immunofluorescence studies 
confirmed these observations in a panel of orthotopic xenografts and human GBM 
specimens. Exposure of non-GSC to low-level exogenous RS generated radiation 
resistance in vitro, confirming RS as a novel determinant of radiation resistance in 
tumor cells. GSC exhibited DNA double strand breaks (DSB) which co-localized with 
'replication factories' and RNA: DNA hybrids. GSC also demonstrated increased 
expression of long neural genes (>1Mbp) containing common fragile sites, supporting 
the hypothesis that replication/transcription collisions are the likely cause of RS in 
GSC. Targeting RS by combined inhibition of ATR and PARP (CAiPi) provided GSC-
specific cytotoxicity and complete abrogation of GSC radiation resistance in vitro. 
These data identify RS as a cancer stem cell-specific target with significant clinical 
potential.  
Significance  
Findings shed new light on cancer stem cell biology and reveal novel therapeutics with 
the potential to improve clinical outcomes by overcoming inherent radioresistance in 
GBM.  
  
  
  
  
  
  
Author Manuscript Published OnlineFirst on July 5, 2018; DOI: 10.1158/0008-5472.CAN-18-0569 
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.  
3  
  
Downloaded from cancerres.aacrjournals.org on July 9, 2018. © 2018 American Association for Cancer 
Research.  
Introduction  
Despite detailed characterization of the genomic and molecular landscape of 
glioblastoma (GBM) life expectancy for patients with this aggressive tumor remains 
extremely poor (1, 2). Standard of care comprises neurosurgical resection followed by 
treatment with radiotherapy and temozolomide, both of which are DNA damaging 
agents (3). Accumulating evidence suggests that the inevitable recurrence of GBM 
after chemoradiation is driven largely by GBM cancer stem-like cells (GSC), which 
drive resistance to DNA damaging therapies through constitutive up regulation of the 
DNA damage response (DDR) (4-6). This DDR phenotype has also been reported in 
cancer stem cells derived from other tumor types (7, 8) and in murine embryonic stem 
cells (9). Despite a decade of research, however, the underlying cause of DDR up 
regulation in GSC remains unclear. While an association with elevated levels of 
reactive oxygen species (ROS) has been reported (10), other studies have attributed 
radiation resistance to reduced levels of ROS in cancer stem cells (11).  
  
A consistent feature of the GSC and cancer stem cell DDR phenotype is the up 
regulation and/or constitutive activation of multiple components of both the DNA repair 
and cell cycle checkpoint pathways (4, 12). Previously, we demonstrated the 
therapeutic relevance of this phenotype by showing that inhibition of both DNA repair 
and cell cycle checkpoint function was required to overcome radioresistance (12). 
While several other reports have confirmed the radiosensitizing potential of DDR 
inhibition at the pre-clinical level (10, 13) progression to the clinic has been frustratingly 
slow. The aim of this study was to elucidate the mechanisms underlying constitutive 
DDR activation in GSC and use this knowledge to identify new therapeutic strategies 
for this cancer of unmet need. Our approach was informed by previous studies 
describing elevated levels of DNA replication stress (RS) in glioma specimens, 
particularly GBM (14), and by emerging evidence that RS can activate a broader 
spectrum of DDR proteins than previously thought (15). RS can be defined as 
inefficient DNA replication that causes replication forks to progress slowly or stall, and 
may be caused by a wide variety of cellular and environmental factors (16, 17). 
Because replication stress can have adverse consequences including permanent DNA 
damage and genomic instability, it evokes a spectrum of cellular responses that act to 
stabilize stalled forks and reduce the risk of fork collapse and consequent DNA 
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damage. Extensive overlap between the cellular responses to RS and radiation 
induced DNA damage supports the hypothesis that constitutive RS might be 
responsible for radiation resistance.  
  
A further question is whether GSC arise from neural progenitor cells, or are the product 
of de-differentiation of malignant glioma cells (18). Embedded within this controversy 
is the related question of whether neural progenitor cells are the cell of origin of GBM 
(19). The recently published observation that neural progenitor cells are prone to 
acquisition of DNA double strand breaks (DSB) at specific chromosomal sites as a 
consequence of RS induced by transcription of long neural genes (20) strengthens the 
rationale for exploring RS in GSC with a view to exploring a potential phenotypic link 
between these two cell populations.  
  
In this study, we demonstrate that GSC exhibit constitutively elevated RS both in vitro 
and in vivo, and that S phase GSC exhibit increased levels of DSB which arise at DNA 
‘replication factories’. We show that exposure to exogenous RS generates significant 
radiation resistance in relatively radiosensitive non-GSC glioma cells. We provide 
evidence to support the hypothesis that RS and consequent activation of the DDR is 
associated with marked overexpression of very long genes, of which the most 
profoundly up regulated are the long neural genes previously shown to harbor DSB in 
neural stem cells (20). Finally, we show that targeting the RS response through 
combined ataxia telangiectasia and rad3 related protein (ATR) inhibition and poly 
(ADP-ribose) polymerase (PARP) inhibition (CAiPi) is an effective approach to 
overcoming the intrinsic radiation resistance of GSC.  
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Materials and Methods  
Derivation and maintenance of primary GBM cell lines  
Primary GBM cell lines E2, G7, R10, R15, R24, R9, S2 were derived from resected 
tumors and maintained as described previously (12, 21), approved by the local 
regional Ethics Committee (LREC ref 04/Q0108/60) in compliance with the UK Human 
Tissue Act 2004 (HTA License ref 12315). Tumorigenicity of paired GSC and 
differentiated GBM cell lines has been described previously (12, 21), (summarized in 
Supplemental table 1). Cell lines were utilized for 20 passages from thaw prior to being 
discarded and were tested for the presence of mycoplasma using the Lonza MycoAlert 
(LT07-318) assay on a 3 monthly basis.  
Immunohistochemistry/immunofluorescence on tissue sections  
Immunofluorescence microscopy on paraffin embedded sections was carried out as 
described previously (22).  Following antigen retrieval sections were incubated 
sequentially with primary and secondary antibodies (Supplemental tables 2 and 3). 
Immunofluorescence images were acquired as Z stacks with a Zeiss 780 confocal 
microscope and processed using maximum intensity projection (MIP) method where 
individual nuclei were selected and quantified for mean fluorescent intensity (MFI) 
values using ImageJ.  Sox2 high and low values were characterized as being above 
and below the median Sox2 MFI value in the whole imaged cell population respectively 
with the MFI of RPA32 being compared between the two groups. A minimum of 150 
(range 150-700) nuclei per sample were quantified from 6-12 63x magnification fields. 
Non fluorescent immunohistochemistry slides were imaged using a Leica Slidepath 
system.    
Clonogenic and neurosphere assays  
Clonogenic survival assays were performed as described previously (12, 23).  Cells 
were treated with DDR inhibitors or DMSO for 1 hour followed by mock or 1-5 Gy 
irradiation. Cells were then incubated for a further 24 hours followed by replacement 
with fresh media without DDR inhibitor. Cell cultures were incubated with aphidicolin 
(Sigma) 0.05 µM (or DMSO) for 72 hours then plated in media with no added 
aphidicolin and irradiated 1 hour after plating.  Colonies were fixed in methanol after 
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2-3 weeks, stained with crystal violet and counted manually. Clonogenic survival data 
were fitted using a linear quadratic model and DMF 0.37 and SER 0.37 values were 
calculated from the fitted curve.  Significance between survival curves was assessed 
by two way ANOVA.  
For neurosphere assay 10 GSC were seeded into each well of a 96 well plate in 100 
µL medium containing 1 µM Olaparib and/or 5 µM  VE821 or DMSO control for 48 
hours or irradiated with 2 Gy ionizing irradiation, followed by the addition of 150 µL of 
fresh media per well. Neurospheres were manually counted under 5x magnification 
after 3-4 weeks.  
Flow cytometry and cell viability  
CD133+ and CD133– populations were isolated using a FACSAria fusion platform 
following labeling with CD133 phycoerythrin (PE) conjugated antibody. Live cells were 
gated (Supplementary figure 1A) and sorted populations were grown in identical stem 
cell culture media for 3 to 7 days prior to harvesting.  
Levels of ROS were measured using dichloro-dihydro-fluorescein diacetate  
(DCFDHA) OxiSelect™ In Vitro ROS Assay Kit according to manufacturer’s protocol 
(Cell Bio Labs Inc.).  Briefly, bulk and GSC were harvested and incubated in PBS 
containing DCFDHA at 37oC for 20 minutes.  Samples were washed twice in PBS 
followed by flow cytometry analysis of live cells.  Dead cells were excluded using DAPI.  
Cell cycle analysis using BrdU was carried out as described previously (12).  Briefly, 
bulk and GSC were incubated with 10 µM BrdU for 35 minutes.  Cells were washed in 
PBS and fixed in 70% ethanol. Samples were co-stained with anti-BrdU-FITC antibody 
(BD Bioscience) and propidium iodide.  Flow cytometry data was collected using 
FACSVerse (BD Biosciences) following doublet discrimination and analyzed using 
FlowJo software (Tristar).  
Cell viability was carried out using CellTiter-Glo® according to manufacturer’s protocol 
(Promega).  Briefly, bulk cells and GSC were plated out in 96 well plates and treated 
with Olaparib (1 µM) and VE821 (1, 3 or 5 µM) for 24 hours or 6 days, replaced with 
fresh media and cultured for a further 5 days followed by followed by detection of 
luminescence (Promega GLOMAX).  
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In vitro immunofluorescence   
Paired bulk and GSC were plated on coverslips coated with Matrigel. For BrdU studies, 
sub confluent paired bulk and/or GSCs were cultured on coverslips and pulse labelled 
with 10µM of BrdU for 30 minutes followed by fixation in 4% formaldehyde. 
Immunofluorescent visualization of RPA and pATM s1981 required removal of non-
chromatin bound nuclear protein using an extraction buffer (24).   Coverslips were 
washed in PBS and denatured in 2M HCl followed by immunostaining with anti-BrdU 
and γ-H2AX antibodies. For DDR inhibition studies, sub confluent cells were incubated 
with Olaparib and/or VE821 for 24 hours and fixed in 4% formaldehyde.  Cells were 
incubated with anti-γ-H2AX, BrdU, RPA 32 and 53BP1 antibodies overnight at 4oC 
followed by incubation with secondary conjugated antibodies (Supplemental tables 2 
and 3). Nuclei were counterstained with Vectashield mount containing DAPI.  Z-stack 
images were acquired under identical parameters using Zeiss LSM 780 confocal 
microscope and analyzed using Zen 2012 (Zeiss).  Co-localization was carried out 
using Zen Black software (Zeiss) from Z-stack images obtained at 40x magnification 
on a Zeiss 780 confocal microscope.  Co-localization coefficients defined as the 
relative number of BrdU pixels that co-localizes with γ-H2AX pixels or relative number 
of γ-H2AX pixels that co-localize with S9.6 pixels; value range 0-1 where 0 denotes 
no co-localization and 1 represents all pixels co-localized and expressed as a 
percentage. 50-75 BrdU positive or 50-100 drug treated cells were analyzed and each 
experiment was repeated at least three times.  
DNA fiber assays  
DNA fiber assays were performed as described previously (15).  Briefly, cultured cells 
were incubated for 20 minutes with media containing CIdU (25µM) followed by PBS 
wash and incubation with media containing IdU (250µM). Cell suspensions were 
pipetted onto glass microscopy slides and lysed. Slides were raised to an angle of 300 
in order to stretch DNA fibers along the slide. Immunostaining was then performed. 
CIdU was detected using anti BrdU (rat) primary antibody (Abcam ab6326 1:400) and 
anti-rat alexa fluorophore 555 (Invitrogen A21434 1:500) secondary. IdU was detected 
using anti BrdU (mouse) primary antibody (BD 347580 1:500) and anti-mouse alexa 
fluorophore 488 (Invitrogen A11017 1:500).  
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Drug treatment and radiation  
ATR inhibitor VE821 (Vertex Pharmaceuticals) and PARP inhibitor olaparib 
(Selleckchem) were dissolved in DMSO and used at concentrations stated. A 
concentration of 5µM VE821 was found to be sufficient to inhibit phosphorylation of 
Chk1s345 following 5Gy radiation (Supplementary figure 1B). An XStrahl RS225 
cabinet at room temperature with 195 kV/15 mA X rays producing a dose rate of 1.6 
Gy per minute was utilized for in vitro radiation studies.  For UV studies, media was 
removed and cells were irradiated with 10 JM-2 UV (Stratalinker, Stratagene).  
Western blotting  
Western blotting was carried out as described previously (23).  
RNA sequencing and bioinformatics  
Total RNA was extracted from 7 paired bulk and GSC followed by generation of 
TruSeq Stranded mRNA library. Samples were run on four V3 flow cells with seven 
indexes per lane and sequenced on an Illumina HiSeq 2000™ to generate 30-45 M 
100 paired-end reads (supplementary materials and methods). RNA-sequencing data 
files were quality checked using FastQC and FastQ-Screen  
(www.bioinformatics.babraham.ac.uk). RNA-sequencing reads were aligned to the 
GRCh37 version of the human genome (25) using Tophat2 version 2.0.10 (26) with 
Bowtie version 2.1.0 (27). Relative expression levels were determined and statistically 
analyzed by a combination of HTSeq and the R 3.0.2 environment, utilising packages 
from the Bioconductor data analysis suite and differential gene expression analysis 
based on the negative binomial distribution using the DESeq package (28).   
Statistical Analyses  
All experiments were repeated and data points reported as mean +/- SEM. Correlation 
of Sox2 and RPA32 integrated density was performed using Spearman ranks due to 
non-normal distribution of these variables. Two way ANOVA was utilized in analyses 
of clonogenic survival curves. Means compared by unpaired students’ t-test. Medians 
were compared by Mann Whitney U test. Statistical analysis and graphs were 
produced using Minitab 16 and Graphpad Prism 6.   
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Results  
  
Radioresistant GSC demonstrate up regulation of DNA replication stress 
response markers   
We previously characterized constitutive DDR activation and associated 
radioresistance of GSC in a panel of primary GBM cell lines propagated as paired 
GSC-enriched (‘GSC’) and GSC-depleted (‘bulk’) cultures (12, 23, 29). Increased 
expression of the GSC markers Nestin and Sox2 along with constitutive up regulation 
and activation of the DDR proteins Chk1 and ATR were confirmed in GSC cultures by 
Western blot (Figure 1A). Using a DCFHDA assay no significant differences in 
baseline ROS levels between GSC and tumor bulk cultures were observed (Figure 
1B), so alternative mechanisms to explain the up regulated DDR in GSC were 
investigated. The consistent pattern of robust up regulation of phosphorylated ATR 
(Ser428) and phosphorylated CHK1 (Ser345) in GSC cultures (Figure 1A) led us to 
hypothesize that GSC populations might exhibit high levels of RS. Replication protein 
A (RPA) binds single stranded DNA (ssDNA) adjacent to collapsed or stalled 
replication forks and is necessary for the activation of ATR kinase in the cellular 
response to RS (30). Validation of the RS phenotype was therefore sought by probing 
for phosphorylation of RPA subunit 32 (RPA32) at Ser4 and Ser8, which is a specific 
marker of RS (31). While phospho-RPA32 (Ser4/8) levels were not detectable by 
Western blot in asynchronous undamaged cells, exacerbation of RS by low doses of 
UV radiation (10 Jm-2) elicited markedly greater phosphorylation of RPA32 in GSC 
than in paired tumor bulk populations (Figure 1C). Pulse labeling with BrdU revealed 
that RPA immunofluorescence intensity was significantly higher in S phase GSC than 
in tumor bulk cells in E2 and G7 cell lines; a trend towards higher intensity in R10 GSC 
narrowly failed to reach statistical significance (Figure 1D and E). While γ-H2AX foci 
are markers of DNA DSB, diffuse nuclear staining is also observed under conditions 
of RS (Supplementary figure 1C) (32, 33) with overall nuclear MFI correlating with 
levels of RS. In E2, G7 and R10 cultures, S phase GSC demonstrated significantly 
higher γ-H2AX diffuse MFI than corresponding tumor bulk cells, providing further 
evidence of elevated RS (Figure 1D and E).   
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Exogenous replication stress can generate a radiation resistance phenotype in 
non-GSC  
The hypothesis that exogenous RS could stimulate the DDR and thus enhance 
radioresistance was tested by incubating bulk cultures of E2, G7 and R10 (which are 
radiosensitive relative to E2, G7 and R10 GSC cultures (12, 23) with 0.05 µM 
aphidicolin for 72 hours prior to irradiation. This low concentration of aphidicolin is 
known to slow DNA replication fork speed and generate RNA: DNA hybrids, leading 
to RS and DDR activation (34, 35) but was not sufficient to induce S phase arrest or 
affect plating efficiency in the absence of radiation in these experiments 
(Supplementary figure S2A i,ii). Exposure to 0.05 µM aphidicolin also generated an 
excess of pATM s1981 foci in exposed cell cultures versus controls, demonstrating 
the activation of DDR DNA DSB pathways by an exogenous source of RS  
(Supplementary figure S2A iii). Importantly, all bulk cell lines examined exhibited a 
significant increase in radioresistance after exposure to low dose aphidicolin, 
confirming that exogenously induced RS can generate measurable radiation 
resistance in vitro (Figure 1F). Survival curves for DMSO versus aphidicolin treated 
irradiated cells were significantly different in all cell lines and dose modifying factors 
(DMF) at 0.37 survival (and 95% confidence intervals) were 0.83 (0.76, 0.9), 0.80 
(0.68, 0.92), 0.82 (0.52, 1.12) in the E2, G7 and R10 cell lines respectively 
(Supplementary figure S2A iv). Surviving fractions at 2 Gy (SF2 Gy) are plotted in 
Supplementary figure S2A v.  
Replicating GSC show altered cell cycle progression and increased replication 
stress in vitro  
Cell cycle studies demonstrated significantly higher proportions of S phase cells in 
GSC than in tumor bulk populations (Figure 2A), despite GSC cultures having similar 
proliferation rates to tumor bulk cultures as shown in previous work (12), indicating 
that GSC have a prolonged S phase duration. A likely explanation is that GSC have 
slower DNA replication velocity than tumor bulk populations because of elevated RS.    
  
We confirmed elevated RS levels in GSC using the ‘gold standard’ DNA fiber assay 
(Figure 2B, C, D) in which immunofluorescent staining of sequentially incorporated 
nucleotide analogues CIdU (red) and IdU (green) facilitates visualization of DNA 
replication structures and direct measurement of DNA replication velocities (Figure 
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2B). GSC cultures exhibited significantly slower DNA replication velocities than 
matched tumor bulk populations (Figure 2B), as well as higher percentages of stalled 
replication forks and fewer ongoing forks, all of which are consistent with increased 
RS (Figure 2C). GSC cultures also showed a consistent trend towards a higher 
percentage of new origin replication structures, however this only reached significance 
in the G7 cell line. To exclude the possibility that these observations were caused by 
GSC culture conditions, we repeated the assay utilising cell populations which were 
sorted using the putative GSC markers CD133 and CD15. CD133+ (GSC) and CD133- 
(non GSC) sorted E2 cells when cultured in identical conditions for several passages, 
maintained GSC and non-GSC (bulk) phenotypes respectively. Importantly, CD133+ 
cells exhibited reduced replication velocity, increased frequency of stalled forks and 
fewer ongoing forks than their CD133- counterparts. Studies in the G7 cell line 
examining CD15+ GSC and CD15- nonGSC cell sorted populations confirmed these 
findings. Further quantitative analyses of bidirectional fork replication structures in the 
E2 cell line supported our hypothesis. Bidirectional forks represent DNA replication 
arising from a single origin and proceeding in two opposing directions. In the absence 
of RS both forks proceed at the same velocity, leading to symmetrical green IdU tracks 
flanking a central red CIdU origin (Figure 2D) i.e. IdU1/IdU2 ≈ 1. E2 GSC exhibited a 
greater proportion of asymmetric versus symmetric bidirectional replication forks 
(Figure 2D) in comparison to E2 bulk cultures (asymmetry defined as >33% difference 
in length between bidirectional elongating IdU fibers i.e. IdU1/IdU2 ≥ 1.33 (36)). This 
effect was also observed in E2 CD133+ versus CD133- sorted cell populations (Figure 
2D). Linear regression of long versus short track length showed significantly different 
gradient values for E2 GSC versus bulk cells and for E2 CD133+ versus CD133- cells 
(Figure 2D). Taken together our results show that RS in GSC is associated with 
reduced DNA replication velocity and higher rates of fork stalling.   
  
GSC exhibit increased numbers of γ-H2AX foci, which co-localize with 
replication factories and RNA: DNA hybrids  
Reduced DNA fork speed and other evidence of elevated RS led us to hypothesize 
that S phase GSC would harbor elevated numbers of DNA DSBs as a direct 
consequence of perturbed DNA replication. Consistent with this hypothesis, S phase  
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GSC identified by BrdU incorporation had significantly more 53BP1 nuclear foci than 
tumor bulk cells (Figure 3A). γ-H2AX foci were also more numerous in S phase GSC 
than tumor bulk cells (Figure 3B). Furthermore, in S phase GSC cultures, γ-H2AX foci 
co-localized with areas of intense BrdU staining, which represent concentrations of 
replication forks and their associated DNA replication machinery and have been 
described as ‘replication factories’ (37). Co-localization of γ-H2AX and BrdU foci was 
significantly higher in GSC than tumor bulk cells (Figure 3C), confirming formation of 
DNA DSBs during aberrant DNA synthesis and providing a likely explanation for 
constitutive DDR activation in GSC.   
  
To explore potential mechanisms responsible for elevated RS in GSC we analyzed 
changes in global gene expression profile between paired GSC and tumor bulk cells 
derived from 7 primary GBM cell lines using high throughput RNA sequencing. We first 
investigated if genes associated with DNA replication and/or the cellular response to 
RS were responsible for elevated RS in GSC. For this purpose, expression levels of 
genes encoding proteins known to be enriched on nascent DNA during unperturbed 
replication (‘replication machinery’ genes) and under conditions of RS induced by 
exposure to hydroxyurea (‘HU stalled forks’ genes) from previously published lists 
were examined in GSC and bulk cell populations (35). Overall, no significant 
differences in expression of ’replication machinery’ or ‘HU stalled fork’ genes were 
observed between GSC and tumor bulk cells (Supplementary figure S2B i,ii). Indeed 
only 2 of 82 transcribed ‘replication machinery’ genes and 4 of 131 transcribed ‘HU 
stalled fork’ genes showed greater than 2.5 fold differential expression between GSC 
and bulk cells. From these data we concluded that altered expression of genes 
associated with nascent DNA was unlikely to be responsible for elevated RS in GSC.   
  
Given that aphidicolin could generate radiation resistance in our non-GSC primary 
GBM cultures (Figure 1F) and is known to generate RNA: DNA hybrids, we next 
investigated the hypothesis that the RS phenotype and its accompanying DDR might 
be associated with replication-transcription machinery collisions with subsequent 
common fragile site (CFS) breakage. CFS are chromosomal loci with an increased 
tendency to develop DNA DSBs under conditions of RS and occur preferentially within 
very large genes (VLG) that are transcriptionally active (35, 38, 39). RNA sequencing 
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data revealed that 14 out of 73 VLGs (>850 Kbp in length) demonstrated a 2.5 fold or 
greater expression in GSC relative to tumor bulk cells (Figure 3D), and that 9 of these 
genes were significantly overexpressed compared to paired bulk populations across 
all 7 cell lines (Figure 3D). If VLGs are defined more stringently as being greater than 
1 Mbp in length, the association remained significant: expression of 5 out of 31 genes 
>1 Mbp was > 2.5 fold greater in GSC than bulk cells, of which 3 were significantly 
overexpressed across all 7 cell lines (Figure 3E). These include: deleted in colorectal 
carcinoma (DCC), cell adhesion molecule 2 (CADM2) and protein tyrosine 
phosphatase receptor type T (PTPRT); which have been shown to play important roles 
in the regulation of neurological development, axon guidance and synapse formation 
(40-42). In order to investigate the contribution of replication transcription collisions to 
DNA DSB generation in GSC, immunofluorescent staining for RNA: DNA hybrids 
(S9.6) and γ-H2AX was carried out and co-localization studies were performed. These 
data demonstrated significant co-localization and overlap of γ-H2AX foci with areas of 
intense S9.6 immunofluorescence in E2 and G7 GSC populations, suggesting a 
prominent role for replication transcription collisions as a source of DNA DSBs in GSC 
(Figure 3F, G).  Consistent with these findings, a recent study by Wei et al 
demonstrated that long neural genes harbor recurrent DNA break clusters in neural 
stem/progenitor cells (20). In addition, a further study has identified intragenic DNA 
origin firing in highly transcribed genes with consequent replication-transcription 
collisions as a mechanism for oncogenic RS (43). Although much debated, neural 
progenitor cells have been proposed as a cell of origin for GBM (44). Therefore the 
description of RS induced DNA DSB formation in transcriptionally active long neural 
genes in neural progenitor cells and the role of intragenic origins in generating 
oncogenic RS are highly relevant to our own data in GSC. We propose that replication-
transcription collisions due to active transcription of long neural genes in GSC is 
responsible for the elevated RS in GSC, resulting in generation of DNA DSBs, 
constitutive DDR activation and consequent therapeutic resistance.   
  
GSC show enhanced replication stress in murine intracranial orthotopic 
xenografts and in human GBM tumor samples  
Having observed compelling evidence of increased RS in GSC in vitro, we investigated 
whether this phenotype was also present in vivo. Dual immunofluorescent staining for 
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RPA32 and the putative GSC marker Sox2 was undertaken in sections of orthotopic 
xenograft tumors derived from CD133+ E2 GSC, which generate highly invasive, 
diffuse tumors and in tumors derived from G7 GSC which form a tumour mass with an 
invasive front typical of human GBM (Figure 4A, B and Supplementary Figure S3A-E). 
Our data showed  a higher MFI of RPA32 staining in high (defined as greater than 
median) Sox2 expressing cells relative to low (less than median) Sox 2 expressing 
cells, consistent with the presence of elevated RS levels in the GSC subpopulation. 
MFI values of Sox2 and RPA32 also showed a significant positive correlation (Figure 
4A, B). Further studies in G7 GSC and CD133+ E2 xenografts confirmed increased 
RS in GSC, utilising alternative GSC (Olig2) and RS (PARP-1) markers 
(Supplementary Figure S4 A-C).  
  
Further immunohistochemical staining for HLA, RPA32, Ki67 and H2AX was 
performed in sections of xenografts derived from CD133+ E2 GSC in which the 
majority of HLA expressing tumor cells stained strongly positive for the GSC marker 
Sox2, (Supplementary Figure S3A, D). Tumour sections also exhibited widespread 
positivity for Ki67, RPA32 and γ-H2AX nuclear staining, indicating high levels of RS in 
replicating GSC in vivo.   
  
To confirm the clinical relevance of these observations, dual immunofluorescence 
staining for Sox2 and RPA32 was performed in human tumor sections from four GBM 
patients (Figure 4C and Supplementary figure S5A-D). Consistent with our earlier 
xenograft studies (Figure 4A and 4B), MFI of RPA32 was significantly higher in cell 
populations which exhibited greater than median MFI of Sox2 (Figure 4C). This 
observation was reproduced using Olig2 as a GSC marker (Supplementary figure 
S5D). RPA32 and Sox2 expression also showed significant positive correlation in all 
tumors examined (Supplementary figure S5A-C).    
  
Inhibition of the RS response in GSC reduces neurosphere formation, 
generates DNA DSBs and abrogates radiation resistance  
Our data indicate that constitutive RS represents a promising, GSC specific 
therapeutic target in GBM, which is a cancer of unmet need. To validate this concept 
we used olaparib, a small molecule inhibitor of poly (ADP-ribose) polymerase  
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(PARP) currently in clinical trials for GBM, and VE821, a potent and specific inhibitor 
of ATR (45), to target key elements of the DDR and RS responses. PARP1 facilitates 
restart of stalled replication forks (46) while ATR has a key role in enabling cells to 
tolerate RS via activation of cell cycle checkpoints, inhibition of global origin firing and 
stabilization of stalled replication forks. Inhibition of ATR (5 μM VE821) significantly 
inhibited neurosphere formation in all three GSC populations tested whereas inhibition 
of PARP (1 μM olaparib) had little or no effect (Figure 5A). However, addition of 
olaparib to VE821, (Combined ATR inhibition and PARP inhibition; ‘CAiPi’) yielded 
significant, supra-additive inhibition of neurosphere formation, which is a fundamental 
property of GSC that requires proliferation and self-renewal. Since tumor bulk cultures 
do not form neurospheres, cell viability assays were undertaken to enable comparison 
of the effects of CAiPi on paired GSC and tumor bulk cultures. Consistent with our 
hypothesis that RS is an integral and targetable characteristic of GSC, these 
populations were significantly more sensitive to CAiPi than tumor bulk cells (Figure 
5B). Addition of PARPi to GSC or bulk cultures did not affect DNA replication velocities 
at the clinically relevant concentrations examined, whereas addition of ATRi or CAiPi 
reduced replication velocities in both GSC and bulk (Figure 5C). Further mechanistic 
studies in E2 cells showed increased induction of γ-H2AX foci and micronuclei (Figure 
5C) in GSC by CAiPi, supporting the concept that higher basal RS in GSC renders 
them particularly vulnerable to increased DNA damage and consequent cell death 
when subjected to inhibition of the DDR. Furthermore, and of profound clinical 
relevance, clonogenic survival assays revealed that CAiPi completely abrogated the 
radioresistance of GSC (Figure 5D), yielding sensitizer enhancement ratios at 37% 
survival of between 2 and 3.6. The radiosensitizing effect of the combination was 
significantly greater in GSC than in bulk cells when SER 0.37 values were compared 
(Figure 5D). Of note, R10 GSC were not radiosensitized by olaparib alone, however 
combined ATR and PARP inhibition resulted in potent radiosensitization. γ-H2AX foci 
analyses confirmed that CAiPi generates an excess of DNA DSBs in GSC in 
combination with radiation, (Figure 5D iv).  
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Discussion   
Radiation resistance of GSC is a well-recognized yet poorly understood phenomenon, 
comprehension of which is vitally important to attempts to improve the therapeutic 
index of current therapy for GBM, since improvements in patient survival depend upon 
our ability to control or eradicate this tumor cell fraction. Despite characterization of up 
regulated DDR in cancer stem cells of different tumor types, the underlying reason for 
activated DDR and consequent radiation resistance in GSC has remained elusive. 
Given the ubiquity of this phenotype in GSC and its prevalence in cancer stem cells of 
other tumor types, deeper understanding of the responsible mechanisms is predicted 
to generate highly appealing targets for clinical therapy.  
   
RS has previously been implicated in the evolution of GBM and other cancers, 
particularly with regard to oncogene-induced senescence and as an anticancer barrier 
in early tumorigenesis (14, 47-49). Indeed, a recent study has suggested reliance upon 
the BRCA1-RRM2 axis for protection from RS in GBM (50). These studies validate 
that RS is a general feature of GBM, and may result in activated DDR in the tumor as 
a whole, however do not address whether RS is of particular importance in GSC, or 
the role of RS in determining DDR activation in GSC and have not shown that RS is 
responsible for radiation resistance. RS has recently been documented in non-
malignant embryonic stem cells, which display constitutively active DDR and 
prolonged S phase occupancy due to abnormal cell cycle progression. These features 
rapidly diminish upon differentiation (9). Our data provide novel insights into the 
importance of RS in the GSC phenotype and direct evidence that RS is responsible 
for the activation of DDR and subsequent radiation resistance in GSC.   
Furthermore, we identify replication transcription collisions as a result of increased 
expression of long neural genes as a likely mechanism for RS in GSC, an observation 
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that correlates closely with recently published studies in neural progenitor cells which 
demonstrate that DSB arising from replication stress are preferentially located in long 
neural genes (20). Indeed, several of these genes, namely DCC, CADM2 and PTPRT 
are significantly overexpressed across a panel of 7 GSC cultures. A further study of 
particular relevance to our data has recently described a novel mechanism for 
oncogenic RS dependent upon intragenic origin firing within highly transcribed genes 
(43). Taken together these data support the controversial hypothesis that GSC derive 
from neural stem cells and provide grounds for further studies.   
Finally we show that RS responses in GSC can be specifically targeted via dual 
inhibition of the key DDR and RS response proteins PARP and ATR. Our data 
demonstrate that GSC are significantly more sensitive to RS response targeting than 
non-GSC because of increased DNA DSB formation in GSC. Interestingly, GSC were 
also sensitized to radiation by dual ATR-PARP inhibition to a significantly greater 
degree than non-GSC, further validating our hypothesis that the radiation resistance 
of GSC is highly dependent on RS. Our results also suggest the feasibility of DDR 
targeting agents as promising therapies for GBM, both alone and in combination with 
radiotherapy.  
Overall, our observations elucidate for the first time the mechanism underlying DDR 
activation and radioresistance in GSC, support a NSC origin for GSC and identify RS 
response as a GSC specific therapeutic target with the potential to improve patient 
outcomes from GBM.  
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Figure 1  Radioresistant GSCs demonstrate up regulation of DNA RS response 
markers, and exogenous RS generates radiation resistance in non-GSCs   
  
A Western blot analysis of RS response and GSC markers in a panel of paired GSC 
and tumor bulk primary GBM cultures. GAPDH loading control. B Flow cytometry plots 
showing baseline levels of reactive oxygen species (ROS) via quantification of 
DCFHDA mean fluorescence intensity (MFI) in GSC and tumor bulk cultures (mean 
+/- SEM, n=3, unpaired t-test, NS=non-significant), C Western blot analysis of 
phospho-RPA32 (Ser4/8) expression in a panel of paired GSC and tumor bulk cells 
following UV mediated activation of RS (10Jm-2). D Immunofluorescence images 
showing γ-H2AX and RPA32 staining in BrdU positive G7 GSC and tumor bulk cells 
under basal conditions. Nuclei are counterstained with DAPI. E Quantification of 
γH2AX and RPA32 MFI in E2, G7 and R10 GSC and tumor bulk cells, (mean +/-SEM, 
n = 3, *p<0.05, **p < 0.01, unpaired t-test). F Clonogenic survival of E2, R10 and G7 
tumor bulk cell lines treated with radiation alone (blue line) and following incubation 
with 0.05µM aphidicolin (red line) for 72 hours prior to irradiation (mean +/-SEM, n = 3 
**p<0.01, ****p<0.001 by two way ANOVA). Representative images of colonies formed 
following 0, 2 and 4 Gy are shown.   
  
  
Figure 2  
Replicating GSCs show altered cell cycle phase progression and enhanced 
replication stress in vitro  
  
A Representative flow cytometry plots and analysis of S-phase populations in R10 and 
R15 GSC and tumor bulk cells by quantification of BrdU incorporation under basal 
conditions (mean +/-SEM, n = 3, * p<0.05, unpaired t-test). B Schematic of DNA fiber 
assay; cells were incubated sequentially with CIdU (red) then IdU (green) followed by 
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lysis and spreading. Representative immunofluorescent images of DNA fibers 
obtained from E2 GSC and bulk cells. Bar charts summarize quantification of IdU and 
CIdU incorporation rates (replication velocities) in GSC and tumor bulk cells in E2, G7 
and R15 cell lines and in E2 CD133+ and CD133- populations and G7 CD15+ and 
CD15- populations, (mean +/-SEM,  n=3, ≥ 500 ongoing replication forks analyzed per 
data point, *p<0.05, unpaired t-test). C Representative immunofluorescent images 
showing ‘new’, ‘ongoing’, ‘stalled’ and ‘bidirectional’ replication fork structures 
following sequential pulse labeling with CIdU (red) and IdU (green) in E2 GSC cultures. 
Bar charts summarize quantification of stalled, ongoing and new replication forks (as 
a percentage of total number of replication structures identified) in paired GSC and 
bulk cultures of E2, R15 and G7 cell lines and also in E2 CD133+ and CD133- and G7 
CD15+ and CD15- sorted populations. (Mean +/SEM, unpaired t test, with approx. 
1800 replication forks identified and counted for each cell line, n ≥ 3). D Schematic 
showing symmetric and asymmetric bidirectional DNA replication fork structures 
observed in DNA fiber assay. Analysis of bidirectional replication fork ratio in E2 GSC 
and bulk cultures and also in E2 CD133+ and CD133- sorted populations. Each point 
represents an individual bidirectional replication fork, with longer IdU (green) track 
plotted on y axis versus shorter IdU track on x axis. Plotted solid black line represents 
a ratio of ‘1’ (i.e. no asymmetry), whilst plotted dotted black line represents a ratio of ≥ 
1.33 (i.e. asymmetry). Table shows gradient of best-fit linear regression lines (95% CI) 
of long IdU versus short IdU tracks in paired E2 GSC and bulk and in E2 CD133+ and 
CD133- populations.  
  
Figure 3 GSCs demonstrate increased numbers of γ-H2AX foci, which co-
localize with replication factories and RNA: DNA hybrids  
A-B Representative immunofluorescence images of G7 GSC and tumor bulk cells 
showing (A) 53BP1 and (B) γ-H2AX  foci in BrdU positive cells under basal conditions, 
with quantification of (A) 53BP1 and (B) γ-H2AX foci per S-phase nucleus in G7 and 
E2 GSC and tumor bulk cells (mean +/-SEM, n = 3, *p<0.05, **p<0.01). C 
Representative images demonstrating co-localization of γ-H2AX foci with BrdU 
replication factories (BrdU foci) in G7 GSC and tumor bulk cells. Percentages of BrdU 
positive replication factories co-localizing with γ-H2AX foci are quantified in E2 and G7 
GSC and tumor bulk cells (mean +/-SEM, n=3, *p<0.05, **p<0.01, unpaired t-test). D 
Mean fold change in the expression of genes across 7 GSC cultures compared to the 
paired tumor bulk cells associated with genes >850kb in length. Numbers of genes 
identified from the RNA sequencing data and total numbers of genes in the published 
gene dataset is shown in brackets and total numbers of up-and down regulated genes 
are indicated in boxes. The numbers and percentages of significantly altered (‘Sig’) 
genes in each dataset are shown and these genes are highlighted in red. Gene shown 
in blue was up regulated 24-fold.  
Mean fold changes across all genes are shown by red lines. Genes >850bp in length 
are significantly up regulated in GSC compared to paired tumor bulk population across 
7 GBM cell lines (one sample t-test, *p<0.05, NS=non-significant). E Heatmap 
illustrating fold changes in expression of the 9 significantly up regulated genes >850bp 
across 7 paired cell lines. F Representative image of immunofluorescent staining for 
RNA: DNA hybrids using S9.6 antibody and γ-H2AX in E2 GSC.  G Table of 
colocalization and overlap coefficients (95% CIs) for γ-H2AX versus S9.6 
immunofluorescence in E2 and G7 GSC.  
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Figure 4 GSCs show enhanced replication stress in murine intracranial 
orthotopic xenografts and in human GBM tumor samples  
  
A and B Representative images (63x magnification) of immunofluorescent staining for 
RPA32 and Sox2 in sections from murine orthotopic intracranial xenografts derived 
from A E2 CD133+ cells and B G7 GSC cultures. Scatter plots showing correlation 
between Sox2 and RPA32 MFI, with corresponding r values (95% CI). Bar charts show 
RPA32 MFI quantified in Sox2 low and Sox2 high populations (defined as below and 
above median Sox2 MFI intensity values respectively; mean +/-SEM, unpaired t test). 
C Representative images (63x magnification) of immunofluorescent staining for 
RPA32 and Sox2 in a section from a resected human  
GBM tumor ‘15 1170.’ Scatter plot showing correlation between Sox2 and RPA32 MFI, 
with corresponding r value (95% CI). Bar chart shows RPA32 MFI quantified in Sox2 
low and Sox2 high populations, (defined as above and below median Sox2 MFI values 
respectively; mean +/-SEM, unpaired t test) in 4 different resected human GBM 
specimens.  
  
Figure 5 Inhibition of RS response inhibits GSC neurosphere formation, 
generates DNA DSBs and abrogates GSC radiation resistance  
A Neurosphere formation by E2, G7 and R10 GSCs following 48 hour exposure to 
PARPi (1μM) or ATRi (5μM) alone, CAiPi or radiation (2Gy). Surviving neurosphere 
fraction is plotted relative to DMSO control (mean+/-SEM, n=3, *p<0.05, **p<0.01, 
***p<0.001, unpaired t-test). B Cell viability of paired E2 and R10 GSC and tumor bulk 
cultures following 24 hour incubation with PARPi alone (1μM), incremental 
concentrations of ATRi alone (1, 3 and 5 μM) or CAiPi.  (Mean +/-SEM, n=3, 
***p<0.001 unpaired t-test). Ci Quantification of CIdU and IdU incorporation rates  
(replication velocities) in E2 GSC and bulk following 24 hour exposure to PARPi (1μM) 
or ATRi (5μM) alone or CAiPi as measured by DNA fiber assay (mean +/- SEM, n = 3, 
unpaired t test. ii Quantification of mean γ-H2AX foci per nuclei and micronuclei 
formation in E2 GSC and tumor bulk cells following 48 hour exposure to ATRi or PARPi 
alone or CAiPi relative to DMSO control (mean+/-SEM, n=3, **p<0.01, unpaired t test). 
Di Clonogenic survival curves derived from R10 GSCs following exposure to DMSO, 
ATRi or PARPi or CAiPi for 1 hour pre and 24 hours post ionizing radiation (0-5Gy) 
(mean+/SEM, n = 3). ii Clonogenic survival curve derived from R10 GSC and paired 
R10 bulk following treatment with DMSO or combined ATRi and PARPi with radiation. 
iii Quantification of radiation sensitizer enhancement ratios for 0.37 survival following 
combined ATRi/PARPi in E2 and R10 GSC and bulk (n≥3, mean +/- SEM). iv 
Quantification of median  γ-H2AX foci per nucleus in E2 GSC and bulk cells following 
exposure to CAiPi or DMSO for 1 hour pre and 24 hours post irradiation with 2Gy or 
sham irradiation. (median +/- range, n = 1, *p<0.05, **p<0.01, Mann Whitney U test).  
  
  
Author Manuscript Published OnlineFirst on July 5, 2018; DOI: 10.1158/0008-5472.CAN-18-0569 
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.  
24  
  
Downloaded from cancerres.aacrjournals.org on July 9, 2018. © 2018 American Association for Cancer 
Research.  
  
 Downloaded from cancerres.aacrjournals.org on July 9, 2018. © 2018 American Association for Cancer 
Research.  
  
 Downloaded from cancerres.aacrjournals.org on July 9, 2018. © 2018 American Association for Cancer 
Research.  
  
 Downloaded from cancerres.aacrjournals.org on July 9, 2018. © 2018 American Association for Cancer 
Research.  
  
 Downloaded from cancerres.aacrjournals.org on July 9, 2018. © 2018 American Association for Cancer 
Research.  
  
 Downloaded from cancerres.aacrjournals.org on July 9, 2018. © 2018 American Association for Cancer 
Research.  
 
  
Author Manuscript Published OnlineFirst on July 5, 2018; DOI: 10.1158/0008-5472.CAN-18-0569  
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.  
 
Replication stress drives constitutive activation of the 
DNA damage response and radioresistance in 
glioblastoma stem-like cells 
   
Ross D Carruthers, Shafiq U Ahmed, Shaliny Ramachandran, et al.  
   
Cancer Res  Published OnlineFirst July 5, 2018. 
Updated version 
   
Access the most recent version of this article at: 
doi:10.1158/0008-5472.CAN-18-0569  
Supplementary 
Material 
   
Access the most recent supplemental material at: 
http://cancerres.aacrjournals.org/content/suppl/2018/07/04/0008-5472.CAN-18-0569.DC1  
   
   
Author 
Manuscript 
Author manuscripts have been peer reviewed and accepted for publication but have not yet 
been edited.  
             
E-mail alerts Sign up to receive free email-alerts related to this article or journal. 
   
Reprints and 
Subscriptions 
To order reprints of this article or to subscribe to the journal, contact the AACR Publications 
Department at pubs@aacr.org. 
   
   
Permissions 
   
To request permission to re-use all or part of this article, use this link 
http://cancerres.aacrjournals.org/content/early/2018/07/04/0008-5472.CAN-18-0569. 
Click on "Request Permissions" which will take you to the Copyright Clearance Center's 
(CCC) Rightslink site.  
Downloaded from cancerres.aacrjournals.org on July 9, 2018. © 2018 American Association for Cancer 
Research.  
